|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses | |||||
| Research and development | |||||
| General and administrative | |||||
| Restructuring and related costs | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Unrealized gain on equity securities | |||||
| Non-cash interest expense related to the sale of future royalties | |||||
| Interest and other income (expense), net | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted-average shares used in computing basic net loss per share | |||||
| Weighted-average shares used in computing diluted net loss per share | |||||
Loading...